These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36183547)

  • 1. COVID-19 patient characteristics and time to viral clearance: A retrospective observational study in a multiethnic population (United Arab Emirates).
    Hafez W
    J Clin Virol; 2022 Dec; 157():105297. PubMed ID: 36183547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and laboratory characteristics of patients hospitalised with COVID-19: clinical outcomes in Abu Dhabi, United Arab Emirates.
    Al Harbi M; Al Kaabi N; Al Nuaimi A; Abdalla J; Khan T; Gasmelseed H; Khan A; Hamdoun O; Weber S
    BMC Infect Dis; 2022 Feb; 22(1):136. PubMed ID: 35135491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and outcome of critically ill patients with coronavirus disease-2019 (COVID-19) pneumonia admitted to a tertiary care center in the United Arab Emirates during the first wave of the SARS-CoV-2 pandemic. A retrospective analysis.
    Ismail K; Bensasi H; Taha A; Nazir A; Abdelkhalek M; Mohamed W; Lodhe D; Buschbeck S; Bauer M; Sakr Y
    PLoS One; 2021; 16(10):e0251687. PubMed ID: 34679109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the Sinopharm's BBIBP-CorV vaccine in preventing hospital admissions and death in infected vaccinees: Results from a retrospective study in the emirate of Abu Dhabi, United Arab Emirates (UAE).
    Ismail AlHosani F; Eduardo Stanciole A; Aden B; Timoshkin A; Najim O; Abbas Zaher W; AlSayedsaleh AlDhaheri F; Al Mazrouie S; Rizvi TA; Mustafa F
    Vaccine; 2022 Mar; 40(13):2003-2010. PubMed ID: 35193793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of asymptomatic and symptomatic Coronavirus Disease 2019 confirmed cases in the Emirate of Abu Dhabi, United Arab Emirates: Observational study.
    Hosani FA; Aden B; Memari SA; Mazrouei SA; Ajab S; Abid M; Alsuwaidi AR; Grivna M; Paulo MS; Sheek-Hussein M
    Medicine (Baltimore); 2021 Mar; 100(12):e25219. PubMed ID: 33761710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of COVID-19 infection in the Emirate of Abu Dhabi, United Arab Emirates: a population-based cross-sectional study.
    Alsuwaidi AR; Al Hosani FI; Al Memari S; Narchi H; Abdel Wareth L; Kamal H; Al Ketbi M; Al Baloushi D; Elfateh A; Khudair A; Al Mazrouei S; Al Humaidan HS; Alghaithi N; Afsh K; Al Kaabi N; Altrabulsi B; Jones M; Shaban S; Sheek-Hussein M; Zoubeidi T
    Int J Epidemiol; 2021 Aug; 50(4):1077-1090. PubMed ID: 33893483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical manifestations and outcome in children with COVID-19 infection in Abu Dhabi: a retrospective single-centre study.
    Alattas B; Azaz A; Rawat D; Midday M; Bitar R
    BMJ Paediatr Open; 2021; 5(1):e001219. PubMed ID: 34841090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body Mass Index and Clinical Outcomes in Adult COVID-19 Patients of Diverse Ethnicities.
    Hafez W; Abdelshakor M; Kishk S; Gebril A; Gador M; Osman S; Abuelsaoud HM; Abdelrahman A
    Healthcare (Basel); 2022 Dec; 10(12):. PubMed ID: 36554099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Disease Severity and Death in Relation to Vitamin D Status among SARS-CoV-2-Positive UAE Residents.
    AlSafar H; Grant WB; Hijazi R; Uddin M; Alkaabi N; Tay G; Mahboub B; Al Anouti F
    Nutrients; 2021 May; 13(5):. PubMed ID: 34069412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Ethnicity and Underlying Comorbidity on COVID-19 Inhospital Mortality: An Observational Study in Abu Dhabi, UAE.
    Deeb A; Khawaja K; Sakrani N; AlAkhras A; Al Mesabi A; Trehan R; Kumar PC; Babiker Z; Nagelkerke N; Fru-Nsutebu E
    Biomed Res Int; 2021; 2021():6695707. PubMed ID: 33708993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological Presentations of COVID-19: Characteristic Features in a Case Series of Hospitalized Patients from Abu Dhabi, UAE.
    Deeb A; Kumar PC; Sakrani N; Trehan RK; Papinenei VR
    Biomed Res Int; 2021; 2021():5822259. PubMed ID: 34423037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors for SARS-CoV-2 Infection Severity in Abu Dhabi.
    Baynouna AlKetbi LM; Nagelkerke N; Abdelbaqi H; ALBlooshi F; AlSaedi M; Almansoori S; AlNuaimi R; AlKhoori A; AlAryani A; AlShamsi M; Kayani F; Alblooshi N; AlKhajeh S; AlFalahi J; AlAmeri S; AlDhahei S
    J Epidemiol Glob Health; 2021 Dec; 11(4):344-353. PubMed ID: 34734381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethnicity-Specific Features of COVID-19 Among Arabs, Africans, South Asians, East Asians, and Caucasians in the United Arab Emirates.
    Al Zahmi F; Habuza T; Awawdeh R; Elshekhali H; Lee M; Salamin N; Sajid R; Kiran D; Nihalani S; Smetanina D; Talako T; Neidl-Van Gorkom K; Zaki N; Loney T; Statsenko Y
    Front Cell Infect Microbiol; 2021; 11():773141. PubMed ID: 35368452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics and Outcomes of Patients With Diabetes Admitted for COVID-19 Treatment in Dubai: Single-Centre Cross-Sectional Study.
    Bhatti R; Khamis AH; Khatib S; Shiraz S; Matfin G
    JMIR Public Health Surveill; 2020 Dec; 6(4):e22471. PubMed ID: 33284130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological and Clinical Characteristics Associated with COVID-19 Severity Among Hospitalized Patients in the United Arab Emirates: A Retrospective Multicentre Study.
    Al-Bluwi N; Agha R; Shukla A; Zeidan RK; AlZubaidi H; Awad M; Hussein A; Abdelbagi M; AlSayed K; Alebaji MB; Shaheen M; Salameh L; Mahboub B; Elkhodary H; Bendardaf R; Mohammed G; Wardat D; Al-Hano Z; Amara HI; Alhajjaj MS; Hamid Q; Halwani R; Saddik B
    J Epidemiol Glob Health; 2024 Jun; 14(2):349-362. PubMed ID: 38407717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of BBIBP-CorV vaccine against severe outcomes of COVID-19 in Abu Dhabi, United Arab Emirates.
    Al Kaabi N; Oulhaj A; Ganesan S; Al Hosani FI; Najim O; Ibrahim H; Acuna J; Alsuwaidi AR; Kamour AM; Alzaabi A; Al Shehhi BA; Al Safar H; Hussein SE; Abdalla JS; Al Mansoori DSN; Al Hammadi AAK; Amari MA; Al Romaithi AK; Weber S; Elavalli S; Eltantawy I; Alghaithi NK; Al Azazi JN; Holt SG; Mostafa M; Halwani R; Khalak H; Elamin W; Beiram R; Zaher W
    Nat Commun; 2022 Jun; 13(1):3215. PubMed ID: 35680857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of critically ill patients infected with COVID-19 in Abu Dhabi, United Arab Emirates.
    Abdallah K; Hamed F; Rahman N; Salam S; Mallat J
    Anaesth Crit Care Pain Med; 2020 Aug; 39(4):483-485. PubMed ID: 32660852
    [No Abstract]   [Full Text] [Related]  

  • 18. Duration and aetiology of extended hospitalization among COVID-19 patients in United Arab Emirates.
    Shaikh NA; Fathima S; Siddique A; Abufool L; Atef Demian B; Mobushar JA; Pradeep R
    East Mediterr Health J; 2023 Nov; 29(10):783-788. PubMed ID: 37947228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of SARS-CoV-2 viral loads in stool samples and nasopharyngeal swabs from COVID-19 patients in the United Arab Emirates.
    Daou M; Kannout H; Khalili M; Almarei M; Alhashami M; Alhalwachi Z; Alshamsi F; Tahseen Al Bataineh M; Azzam Kayasseh M; Al Khajeh A; Hasan SW; Tay GK; Feng SF; Ruta D; Yousef AF; Alsafar HS;
    PLoS One; 2022; 17(9):e0274961. PubMed ID: 36137134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Influencing Viral Clearance in Mild COVID-19 and Clinical Characteristics of Asymptomatic Patients.
    Shu HM; He S; Sun Y; Lin CQ; Lu YF; Liu J; Wu T; Li L; Ding GZ; Shi W; Liu ZJ
    Biomed Res Int; 2021; 2021():5909612. PubMed ID: 33728332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.